| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 07/15/1999 | WO1999035162A1 Therapeutic liposome-encapsulated immunomodulators |
| 07/14/1999 | EP0928790A1 Thiazole derivatives |
| 07/14/1999 | EP0928291A1 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
| 07/14/1999 | CN1044117C Compound for inhibition of HIV protease, its preparing method and its drug use |
| 07/13/1999 | US5922878 Amino acid derivatives, processes for preparing them and pharmaceutical compositions containing these compounds |
| 07/13/1999 | US5922837 Against malaria, toxoplasmosis, coccidiosis |
| 07/13/1999 | US5922763 Biphenyl derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 07/13/1999 | US5922681 Administering antagonists to treat asthma, hypertension, preeclampsia, myocardial infarction, diabetes, renal failure, septic shock, and other disease states associated with elevated levels of endothelin |
| 07/13/1999 | US5922553 Method of detecting protein by immuno RNA |
| 07/13/1999 | US5922319 Methods of treating eye conditions with human leukocyte elastase (HLE) inhibitory agents |
| 07/13/1999 | CA2176037C Antithrombotic amidinophenylalanine and amidinopyridylalanine derivatives |
| 07/08/1999 | WO1999033864A1 Peptide derivatives |
| 07/08/1999 | WO1999033863A1 Peptide chelators that predominately form a single stereoisomeric species upon coordination to a metal center |
| 07/08/1999 | WO1999033818A1 Vitamin e derivatives |
| 07/08/1999 | WO1999033801A1 Tripeptidyl peptidase inhibitors |
| 07/08/1999 | WO1999033799A1 Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith |
| 07/08/1999 | WO1999033787A1 Amino acid derivatives |
| 07/08/1999 | WO1999014231A3 Bifidus stimulating peptides and its uses |
| 07/08/1999 | WO1999011606A3 Inhibitors of protein tyrosine phosphatase |
| 07/08/1999 | CA2316392A1 Peptide chelators that predominately form a single stereoisomeric species upon coordination to a metal center |
| 07/08/1999 | CA2315679A1 Vitamin e derivatives |
| 07/07/1999 | EP0927192A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 07/07/1999 | EP0927191A2 Anti-inflammatory peptides and uses thereof |
| 07/07/1999 | EP0927190A1 Central nervous system-derived immune privilege factor and uses thereof |
| 07/07/1999 | EP0926955A1 Conjugates useful in the treatment of prostate cancer |
| 07/07/1999 | EP0587799B1 Inhibitors of cathepsin g and elastase for preventing connective tissue degradation |
| 07/07/1999 | CN1222081A Method for prevention and treatment of mastitis |
| 07/06/1999 | US5919926 Salinamides |
| 07/06/1999 | US5919777 Compounds with growth hormone releasing properties |
| 07/06/1999 | US5919769 Antiinflammatory agent |
| 07/06/1999 | US5919765 Inhibitors of factor XA |
| 07/06/1999 | US5919671 Antitumor antibiotic BMS-199687 |
| 07/06/1999 | US5919639 Ii peptide therapeutics to enhance antigen presentation |
| 07/06/1999 | US5919433 Macrocyclic metal complex carboxylic acids, their use as well as process for their production |
| 07/01/1999 | WO1999032510A1 Kappa receptor opioid peptides |
| 07/01/1999 | WO1999032509A2 Hemiasterlin analogs |
| 07/01/1999 | WO1999032428A2 Synthesis of diamines |
| 07/01/1999 | WO1999032000A1 Sweetener composition |
| 07/01/1999 | WO1999031999A1 Granular sweetener |
| 07/01/1999 | CA2312826A1 Hemiasterlin analogs |
| 06/30/1999 | EP0926543A1 Silver halide emulsions with recombinant collagen suitable for photographic application and also the preparation thereof |
| 06/30/1999 | EP0756602B1 Cck or gastrin modulating 5-heterocyclic-1,5-benzodiazepines |
| 06/29/1999 | US5917670 In a hard disk drive |
| 06/29/1999 | US5916888 Imidazo 1,5A!pyridine derived serine protease inhibitors |
| 06/29/1999 | US5916887 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 06/29/1999 | US5916878 Dipeptide of either gamma-glutamyl-l-tryptophan or beta-aspartyl-l-tryptophan; administering to the patients to reduce the risks infections from microorganism |
| 06/29/1999 | US5916877 For detecting serine proteases in cells; enzyme inhibitors |
| 06/29/1999 | US5916872 Efficiency; long half-life |
| 06/24/1999 | WO1999031124A1 Cholic acid-based scaffolds for multidimensional molecular presentation of peptides |
| 06/24/1999 | WO1999031122A1 Antipicornaviral compounds and methods for their use and preparation |
| 06/24/1999 | WO1999031121A2 Branched building units for synthesizing cyclic peptides |
| 06/24/1999 | WO1999031052A1 Novel metalloproteinase inhibitors |
| 06/24/1999 | WO1999031049A1 Neuroprotective agents |
| 06/24/1999 | WO1999030732A1 Gamma-conopeptides |
| 06/24/1999 | WO1999030575A1 Sweetener compositions containing aspartame and aspartame derivative |
| 06/24/1999 | WO1999030574A1 Mixed crystals comprising aspartame and aspartame derivative and process for producing the same |
| 06/24/1999 | WO1999030562A1 Method for treating fibroproliferative disorders by inhibitors of protein hydroxylation |
| 06/24/1999 | WO1999019352A3 Methods and compositions to alter the cell surface expression of phosphatidylserine and other clot-promoting plasma membrane phospholipids |
| 06/24/1999 | WO1999009977A9 1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives |
| 06/24/1999 | CA2315222A1 Branched building units for synthesizing cyclic peptides |
| 06/24/1999 | CA2314686A1 Gamma-conopeptides |
| 06/24/1999 | CA2313649A1 Novel metalloproteinase inhibitors |
| 06/24/1999 | CA2312940A1 Antipicornaviral compounds and methods for their use and preparation |
| 06/23/1999 | EP0923604A1 Cysteine-containing or methioine-containing peptides with immunomodulatory effects |
| 06/23/1999 | EP0923603A1 Oligopeptide transporters |
| 06/23/1999 | EP0923601A2 Librairies of backbone-cyclized peptidomimetics |
| 06/23/1999 | EP0923564A1 Pharmaceutical compounds |
| 06/23/1999 | EP0923553A1 Stable non-hygroscopic crystalline form of n- n-n-(4-(piperidin-4-yl)butanoyl)-n-ethylglycyl] compounds |
| 06/23/1999 | EP0923372A1 Pyridinone thrombin inhibitors |
| 06/23/1999 | CN1220670A Inhibitor and stimulator of stem cell proliferationa and use thereof |
| 06/23/1999 | CN1220609A Growth hormone component and bone anti-resorptive agent in cyclic (coherence) treatment of osteoporosis |
| 06/22/1999 | US5914348 Substance FA-70D, process for producing the same, and uses thereof |
| 06/22/1999 | US5914319 Antithrombotic agents |
| 06/19/1999 | CA2225325A1 Hemiasterlin analogs |
| 06/17/1999 | WO1999029716A1 Echinocandin derivatives, preparation method and application as anti-fungal agents |
| 06/17/1999 | WO1999029713A1 Method for separating and purifying aspartame and aspartame derivative |
| 06/17/1999 | WO1999029712A1 Peptide-based gemini compounds |
| 06/17/1999 | WO1999029664A1 New compounds |
| 06/17/1999 | WO1999029311A1 Hiv/fiv protease inhibitors having a small p3 residue |
| 06/17/1999 | CA2312941A1 Peptide-based gemini compounds |
| 06/17/1999 | CA2311295A1 Echinocandin derivatives, preparation method and application as anti-fungal agents |
| 06/16/1999 | EP0922696A2 Urea derivatives of alpha, omega-diaminoacids and peptides |
| 06/16/1999 | EP0922054A1 Anticoagulant peptidyl-arginine aldehyde derivatives |
| 06/16/1999 | EP0827507B1 Protease inhibiting succinic acid derivatives |
| 06/16/1999 | EP0753003B1 Aziridine derivatives, their production and use |
| 06/16/1999 | EP0711283B1 Tetrahydro-1h-benzazepinones and hexahydroazepinones as selective cholecystokinin-b receptor antagonists |
| 06/16/1999 | EP0684830B1 Inhibitors of thrombosis |
| 06/16/1999 | CN1219938A Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (VIP) |
| 06/16/1999 | CN1043647C Peptide compound |
| 06/15/1999 | US5912233 Methods and peptides for the treatment of non-IgE-mediated diseases |
| 06/10/1999 | WO1999028345A1 Conjugates useful in the treatment of prostate cancer |
| 06/10/1999 | WO1998004582A8 Isolated peptides derived from mage-2 |
| 06/10/1999 | CA2311615A1 Conjugates useful in the treatment of prostate cancer |
| 06/09/1999 | EP0920510A1 GnRH-LEUKOTOXIN CHIMERAS |
| 06/09/1999 | EP0920448A1 Truncated glial cell line-derived neurotrophic factor |
| 06/09/1999 | EP0920445A1 Synthetic peptides and their use in cosmetic or dermopharmaceutical compositions |
| 06/09/1999 | EP0920444A1 C-TERMINAL MODIFIED (N-SUBSTITUTED)-2-INDOLYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES |
| 06/09/1999 | EP0920325A2 Tetrapeptide derivatives of dolastatin as antitumor agents |
| 06/09/1999 | EP0808458A4 Dioxetane compounds for the chemiluminescent detection of proteases, methods of use and kits therefore |
| 06/09/1999 | EP0661986B1 Brain-enhanced delivery of neuroactive peptides by sequential metabolism |